Professional Documents
Culture Documents
Cardiovascular
“As for me, except for an occasional heart attack, I feel as young as I ever ``Embryology 274
did.”
—Robert Benchley ``Anatomy 277
“Hearts will never be practical until they are made unbreakable.” ``Physiology 278
—The Wizard of Oz
``Pathology 294
“As the arteries grow hard, the heart grows soft.”
—H. L. Mencken ``Pharmacology 310
“Nobody has ever measured, not even poets, how much the heart can
hold.”
—Zelda Fitzgerald
“It is not the size of the man but the size of his heart that matters.”
—Evander Holyfield
The cardiovascular system is one of the highest yield areas for the
boards and, for some students, may be the most challenging. Focusing
on understanding the mechanisms instead of memorizing the details
can make a big difference, especially for this topic. Pathophysiology of
atherosclerosis and heart failure, MOA of drugs (particular physiology
interactions) and their adverse effects, ECGs of heart blocks, the cardiac
cycle, and the Starling curve are some of the more high-yield topics.
Differentiating between systolic and diastolic dysfunction is also very
important. Heart murmurs and maneuvers that affect these murmurs
have also been high yield.
273
CARDIOVASCULAR—EMBRYOLOGY
``
Heart morphogenesis First functional organ in vertebrate embryos; beats spontaneously by week 4 of development.
Cardiac looping Primary heart tube loops to establish left-right Defect in left-right Dynein (involved in L/R
polarity; begins in week 4 of gestation. asymmetry) can lead to Dextrocardia, as
seen in Kartagener syndrome (1° ciliary
Dyskinesia).
Septation of the chambers
Atria eptum primum grows toward endocardial
S 6. (Not shown) Septum secundum and septum
cushions, narrowing foramen primum. primum fuse to form the atrial septum.
Foramen secundum forms in septum 7. (Not shown) Foramen ovale usually closes
primum (foramen primum disappears). soon after birth because of LA pressure.
Septum secundum develops as foramen Patent foramen ovale—caused by failure of
secundum maintains right-to-left shunt. septum primum and septum secundum
Septum secundum expands and covers most to fuse after birth; most are left untreated.
of the foramen secundum. The residual Can lead to paradoxical emboli (venous
foramen is the foramen ovale. thromboemboli that enter systemic arterial
Remaining portion of septum primum forms circulation), similar to those resulting from
valve of foramen ovale. an ASD.
Aorticopulmonary
septum
RA LA RA LA RA LA
Interventricular
foramen
Membranous
Atrioventricular interventricular
canals septum
Muscular
interventricular
septum
Outflow tract Neural crest and endocardial cell migrations Conotruncal abnormalities associated with
formation truncal and bulbar ridges that spiral failure of neural crest cells to migrate:
and fuse to form aorticopulmonary septum Transposition of great vessels.
ascending aorta and pulmonary trunk. Tetralogy of Fallot.
Persistent truncus arteriosus.
Valve development Aortic/pulmonary: derived from endocardial Valvular anomalies may be stenotic, regurgitant,
cushions of outflow tract. atretic (eg, tricuspid atresia), or displaced (eg,
Mitral/tricuspid: derived from fused endocardial Ebstein anomaly).
cushions of the AV canal.
Fetal-postnatal derivatives
FETAL STRUCTURE POSTNATAL DERIVATIVE NOTES
AllaNtois urachus MediaN umbilical ligament Urachus is part of allantoic duct between
bladder and umbilicus.
Ductus arteriosus Ligamentum arteriosum
Ductus venosus Ligamentum venosum
Foramen ovale Fossa ovalis
Notochord Nucleus pulposus
UmbiLical arteries MediaL umbilical ligaments
Umbilical vein Ligamentum teres hepatis (round ligament) Contained in falciform ligament.
CARDIOVASCULAR—ANATOMY
``
A The most posterior part of the heart is the left atrium A ; enlargement can cause dysphagia (due to
compression of the esophagus) or hoarseness (due to compression of the left recurrent laryngeal
RV
nerve, a branch of the vagus nerve).
LV
RA Pericardium consists of 3 layers (from outer to inner):
LA
Fibrous pericardium
pv
Ao
Parietal layer of serous pericardium
Visceral layer of serous pericardium
Pericardial cavity lies between parietal and visceral layers.
Pericardium innervated by phrenic nerve. Pericarditis can cause referred pain to the shoulder.
CARDIOVASCULAR—PHYSIOLOGY
``
Cardiac output CO = stroke volume (SV) × heart rate (HR) During the early stages of exercise, CO is
Fick principle: maintained by HR and SV. During the late
stages of exercise, CO is maintained by HR
rate of O2 consumption
CO = only (SV plateaus).
arterial O2 content − venous O2 content
Diastole is preferentially shortened with HR;
Mean arterial pressure (MAP) = CO × total less filling time CO (eg, ventricular
peripheral resistance (TPR) tachycardia).
MAP (at resting HR) = 2 ⁄3 diastolic pressure
+ 1⁄3 systolic pressure
Pulse pressure = systolic pressure – diastolic pressure pulse pressure in hyperthyroidism, aortic
Pulse pressure is proportional to SV, inversely regurgitation, aortic stiffening (isolated systolic
proportional to arterial compliance. hypertension in elderly), obstructive sleep
apnea ( sympathetic tone), anemia, exercise
SV = end-diastolic volume (EDV) − end-systolic
(transient).
volume (ESV)
pulse pressure in aortic stenosis, cardiogenic
shock, cardiac tamponade, advanced heart
failure (HF).
Normal
↓ inotropy
Va
sc
ula
r fun
Mean ↓
↓ volume, TPR
cti
systemic
on
Intersection of curves = operating point of heart (ie, venous return and CO are equal).
Pressure-volume loops and cardiac cycle The black loop represents normal cardiac
physiology.
140
Contractility Afterload
SV Aortic pressure
120 EF SV Phases—left ventricle:
ESV S2 ESV Isovolumetric contraction—period
Left ventricular pressure (mm Hg)
Systole Diastole
Heart sounds:
S1—mitral and tricuspid valve closure. Loudest
ventricular filling
Rapid ejection
at mitral area.
Isovolumetric
Isovolumetric
contraction
ventricular
Reduced
ejection
systole
filling
Atrial
Ventricular
volume
Jugular venous pulse (JVP):
a wave—atrial contraction. Absent in atrial
fibrillation (AF).
c wave—RV contraction (closed tricuspid valve
a bulging into atrium).
c
Jugular v
x descent—downward displacement of closed
venous x y tricuspid valve during rapid ventricular
pulse R ejection phase. Reduced or absent in tricuspid
regurgitation and right HF because pressure
P T gradients are reduced.
ECG P
Q v wave— right atrial pressure due to filling
S (“villing”) against closed tricuspid valve.
y descent—RA emptying into RV. Prominent
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 in constrictive pericarditis, absent in cardiac
Time (sec) tamponade.
Splitting
Normal splitting Inspiration drop in intrathoracic pressure
E
venous return RV filling RV
S1 A2 P2
stroke volume RV ejection time
delayed closure of pulmonic valve. I
Normal delay
pulmonary impedance ( capacity of the
pulmonary circulation) also occurs during EE
Aortic area:
Systolic murmur
Aortic stenosis Pulmonic area:
Flow murmur Systolic ejection murmur
1
(eg, physiologic murmur) Pulmonic stenosis
Aortic valve sclerosis Atrial septal defect
2 Flow murmur
Left sternal border: A P
Diastolic murmur 3 Tricuspid area:
Aortic regurgitation Holosystolic murmur
Pulmonic regurgitation 4 Tricuspid regurgitation
Systolic murmur Ventricular septal defect
Hypertrophic T Diastolic murmur
5
cardiomyopathy Tricuspid stenosis
M
Aortic 6
Mitral area (apex):
Pulmonic Holosystolic murmur
Tricuspid 7
Mitral regurgitation
Mitral
Systolic murmur
Mitral valve prolapse
Diastolic murmur
Mitral stenosis
Heart murmurs
S1 S2
Systolic
Aortic stenosis Crescendo-decrescendo systolic ejection murmur and soft S2 (ejection click may
be present). LV >> aortic pressure during systole. Loudest at heart base; radiates to
S1 S2
carotids. “Pulsus parvus et tardus”—pulses are weak with a delayed peak. Can lead
to Syncope, Angina, and Dyspnea on exertion (SAD). Most commonly due to age-
S1 S2
related calcification in older patients (> 60 years old) or in younger patients with
S1 S2
early-onset calcification of bicuspid aortic valve.
Mitral/tricuspid
S1
regurgitation
S2
Holosystolic, high-pitched “blowing murmur.”
Mitral—loudest at apex and radiates toward axilla. MR is often due to ischemic heart
S1 MC S2
disease (post-MI), MVP, LV dilatation.
Tricuspid—loudest at tricuspid area. TR commonly caused by RV dilatation.
S1 S2
Rheumatic fever and infective endocarditis can cause either MR or TR.
S1
S1 S2
S2
Mitral
S1 valve prolapse
S2 Late systolic crescendo murmur with midsystolic click (MC; due to sudden tensing
S1 S2 of chordae tendineae). Most frequent valvular lesion. Best heard over apex. Loudest
S1
S1 MC S2
S2
S1 S2
just before S2. Usually benign. Can predispose to infective endocarditis. Can be
S1 S2 OS caused by myxomatous degeneration (1° or 2° to connective tissue disease such as
S1 S2
S1 S2 Marfan or Ehlers-Danlos syndrome), rheumatic fever, chordae rupture.
S1 S2
S2
Ventricular
S1 septal
MC defect
S2 Holosystolic, harsh-sounding murmur. Loudest at tricuspid area.
S1 S2
S1 S2
S1
S1 S2
S2
S1 S2 OS
S1 S2
S1 MC S2
Diastolic
S1
S1 MC S2
S2
S1 MC S2
Aortic regurgitation High-pitched “blowing” early diastolic decrescendo murmur. Long diastolic
S1 S2 OS
murmur, hyperdynamic pulse, and head bobbing when severe and chronic. Wide
S1 S2
S1 S2
S2 pulse pressure. Often due to aortic root dilation, bicuspid aortic valve, endocarditis,
S1 S2 rheumatic fever. Progresses to left HF.
S1 S2
Mitral
S1 stenosis S2 OS Follows opening snap (OS; due to abrupt halt in leaflet motion in diastole, after
S1 MC S2 OS
rapid opening due to fusion at leaflet tips). Delayed rumbling mid-to-late diastolic
S1 S2 OS
murmur ( interval between S2 and OS correlates with severity). LA >> LV
S1 S2 pressure during diastole.
S1
S1 S2
S2 Often a late (and highly specific) sequela of rheumatic fever. Chronic MS can
S1 S2
result in LA dilatation dysphagia/hoarseness via compression of esophagus/left
recurrent laryngeal nerve, respectively.
S1 S2 OS
Continuous
Patent ductus arteriosus Continuous machine-like murmur. Best heard at left infraclavicular area. Loudest at
S2. Often due to congenital rubella or prematurity.
S1 S2
“PDA’s (Public Displays of Affection) are continuously annoying.”
Membrane ATP
Intracellular
K+ K+ Ca2+
pump exchanger
K+ Na+ Ca2+
“Leak” currents
Pacemaker action Occurs in the SA and AV nodes. Key differences from the ventricular action potential include:
potential
Phase 0 = upstroke—opening of voltage-gated Ca2+ channels. Fast voltage-gated Na+ channels are
permanently inactivated because of the less negative resting potential of these cells. Results in a slow
conduction velocity that is used by the AV node to prolong transmission from the atria to ventricles.
Phases 1 and 2 are absent.
Phase 3 = repolarization—inactivation of the Ca2+ channels and activation of K+ channels
K+ efflux.
Phase 4 = slow spontaneous diastolic depolarization due to If (“funny current”). If channels
responsible for a slow, mixed Na+/K+ inward current; different from INa in phase 0 of ventricular
action potential. Accounts for automaticity of SA and AV nodes. The slope of phase 4 in the SA
node determines HR. ACh/adenosine the rate of diastolic depolarization and HR, while
catecholamines depolarization and HR. Sympathetic stimulation the chance that If channels
are open and thus HR.
–20 ICa IK
Millivolts
Phase 0 Phase 3
Threshold
–40
Phase 4
–60
If (Na+ and K+)
–80
100 msec
5 mm +1.0
0.2 seconds
5 mm +1.0
Aorta 0.2 seconds
R
Aorta R
Superior
Superior P-R S-T
vena cava P-R segmentS-T
vena cava BachmannBachmann segment +0.5
+0.5
segment segment
bundle bundle
SA node SA node
T T
P P J point
J point
AV node AV node UU
Left bundle
Left bundle 00mV
mV
branch branch
Bundle of His Q Q
Bundle of His
S S
P-R QRS
P-R interval
QRS interval
interval interval Q-T interval –0.5
Right bundle Left anterior Q-T interval –0.5
Right bundle branch Left anterior
fascicle
branch fascicle
Purkinje fibers Atrial Ventricular Ventricular
Purkinje fibers Left posterior repolarization
Atrial depolarization depolarization
Ventricular Ventricular
Left posterior
fascicle depolarization depolarization repolarization
fascicle
Brugada syndrome Autosomal dominant disorder most common in Asian males. ECG pattern of pseudo-right bundle
branch block and ST elevations in V1-V3. risk of ventricular tachyarrhythmias and SCD. Prevent
SCD with implantable cardioverter-defibrillator (ICD).
Shortened PR interval
Normal PR interval
ECG tracings
RHYTHM DESCRIPTION EXAMPLE
Atrial fibrillation Chaotic and erratic baseline with no discrete P waves in between RR1 ≠ RR2 ≠ RR3 ≠ RR4
irregularly spaced QRS complexes. Irregularly irregular
heartbeat. Most common risk factors include hypertension and
coronary artery disease (CAD). Can lead to thromboembolic
Irregular baseline (absent P waves)
events, particularly stroke.
Treatment includes anticoagulation, rate control, rhythm control,
and/or cardioversion.
Atrial flutter A rapid succession of identical, back-to-back atrial depolarization RR1 = RR2 = RR3
waves. The identical appearance accounts for the “sawtooth”
appearance of the flutter waves.
Treat like atrial fibrillation. Definitive treatment is catheter
4:1 sawtooth pattern
ablation.
Ventricular A completely erratic rhythm with no identifiable waves. Fatal
fibrillation arrhythmia without immediate CPR and defibrillation.
No discernible rhythm
AV block
First-degree The PR interval is prolonged (> 200 msec). Benign and
AV block asymptomatic. No treatment required.
Second-degree
AV block
Mobitz type I Progressive lengthening of PR interval until a beat is “dropped”
(Wenckebach) (a P wave not followed by a QRS complex). Usually
asymptomatic. Variable RR interval with a pattern (regularly
irregular). PR 1
< PR1 < PR2 < PR3 P wave, absent QRS
Mobitz type II Dropped beats that are not preceded by a change in the length of
the PR interval (as in type I).
May progress to 3rd-degree block. Often treated with pacemaker.
PR1 = PR1 = PR2 P wave, absent QRS
Third-degree The atria and ventricles beat independently of each other. P waves and QRS complexes not rhythmically
(complete) associated. Atrial rate > ventricular rate. Usually treated with pacemaker. Can be caused by Lyme
AV block disease.
RR1 = RR2
Atrial natriuretic Released from atrial myocytes in response to blood volume and atrial pressure. Acts via cGMP.
peptide Causes vasodilation and Na+ reabsorption at the renal collecting tubule. Dilates afferent renal
arterioles and constricts efferent arterioles, promoting diuresis and contributing to “aldosterone
escape” mechanism.
B-type (brain) Released from ventricular myocytes in response to tension. Similar physiologic action to ANP,
natriuretic peptide with longer half-life. BNP blood test used for diagnosing HF (very good negative predictive value).
Available in recombinant form (nesiritide) for treatment of HF.
Autoregulation How blood flow to an organ remains constant over a wide range of perfusion pressures.
ORGAN FACTORS DETERMINING AUTOREGULATION
Heart Local metabolites (vasodilatory): adenosine, The pulmonary vasculature is unique in that
NO, CO2, O2 alveolar hypoxia causes vasoconstriction so
Brain Local metabolites (vasodilatory): CO2 (pH) that only well-ventilated areas are perfused. In
other organs, hypoxia causes vasodilation.
Kidneys Myogenic and tubuloglomerular feedback
Lungs Hypoxia causes vasoconstriction
Skeletal muscle Local metabolites during exercise: CO2, H+, CHALK.
Adenosine, Lactate, K+
At rest: sympathetic tone
Skin Sympathetic stimulation most important
mechanism for temperature control
Capillary fluid Starling forces determine fluid movement through capillary membranes:
exchange Pc = capillary pressure—pushes fluid out of capillary
Pi = interstitial fluid pressure—pushes fluid into capillary
πc = plasma colloid osmotic (oncotic) pressure—pulls fluid into capillary
πi = interstitial fluid colloid osmotic pressure—pulls fluid out of capillary
Jv = net fluid flow = K f [(Pc − Pi) − σ(πc − πi)]
K f = capillary permeability to fluid
σ = reflection coefficient (measure of capillary permeability to protein)
Edema—excess fluid outflow into interstitium commonly caused by:
capillary pressure ( Pc; eg, HF)
plasma proteins ( πc; eg, nephrotic syndrome, liver failure, protein malnutrition)
capillary permeability ( K f ; eg, toxins, infections, burns)
interstitial fluid colloid osmotic pressure ( πi; eg, lymphatic blockage)
Interstitium
ry
Capilla
CARDIOVASCULAR—PATHOLOGY
``
VSD LV
RV
Atrial septal defect Defect in interatrial septum C ; wide, fixed split O2 saturation in RA, RV, and pulmonary
C
S2. Ostium secundum defects most common artery. May lead to paradoxical emboli
ASD
and usually an isolated finding; ostium (systemic venous emboli use ASD to bypass
primum defects rarer and usually occur lungs and become systemic arterial emboli).
with other cardiac anomalies. Symptoms
range from none to HF. Distinct from patent
foramen ovale in that septa are missing tissue
rather than unfused.
Patent ductus In fetal period, shunt is right to left (normal). “Endomethacin” (indomethacin) ends patency
arteriosus In neonatal period, pulmonary vascular of PDA; PGE keeps ductus Going (may be
D
resistance shunt becomes left to right necessary to sustain life in conditions such as
progressive RVH and/or LVH and HF. transposition of the great vessels).
Associated with a continuous, “machine-like” PDA is normal in utero and normally closes only
murmur. Patency is maintained by PGE after birth.
synthesis and low O2 tension. Uncorrected
PDA D can eventually result in late cyanosis
in the lower extremities (differential cyanosis).
Eisenmenger Uncorrected left-to-right shunt (VSD, ASD,
syndrome PDA) pulmonary blood flow pathologic
E
remodeling of vasculature pulmonary
arterial hypertension. RVH occurs to
compensate shunt becomes right to
left. Causes late cyanosis, clubbing E , and L
RVH
OTHER ANOMALIES
Coarctation of the Aortic narrowing F near insertion of ductus arteriosus (“juxtaductal”). Associated with bicuspid
aorta aortic valve, other heart defects, and Turner syndrome. Hypertension in upper extremities and
F
weak, delayed pulse in lower extremities (brachial-femoral delay). With age, intercostal arteries
Coarct
enlarge due to collateral circulation; arteries erode ribs notched appearance on CXR.
Complications include HF, risk of cerebral hemorrhage (berry aneurysms), aortic rupture, and
Desc Ao possible endocarditis.
Asc Ao
PREDISPOSES TO CAD, LVH, HF, atrial fibrillation; aortic dissection, aortic aneurysm; stroke; chronic kidney disease
(hypertensive nephropathy); retinopathy.
Hyperlipidemia signs
Xanthomas Plaques or nodules composed of lipid-laden histiocytes in skin A , especially the eyelids
(xanthelasma B ).
Tendinous xanthoma Lipid deposit in tendon C , especially Achilles.
Corneal arcus Lipid deposit in cornea. Common in elderly (arcus senilis D ), but appears earlier in life with
hypercholesterolemia.
A B C D
Arteriosclerosis Hardening of arteries, with arterial wall thickening and loss of elasticity.
Arteriolosclerosis Common. Affects small arteries and arterioles. Two types: hyaline (thickening of vessel walls in
essential hypertension or diabetes mellitus A ) and hyperplastic (“onion skinning” in severe
hypertension B with proliferation of smooth muscle cells).
Mönckeberg sclerosis Uncommon. Affects medium-sized arteries. Calcification of internal elastic lamina and media of
(medial calcific arteries vascular stiffening without obstruction. “Pipestem” appearance on x-ray C . Does not
sclerosis) obstruct blood flow; intima not involved.
A B C
Atherosclerosis Very common. Disease of elastic arteries and large- and medium-sized muscular arteries; a form of
arteriosclerosis caused by buildup of cholesterol plaques.
LOCATION Abdominal aorta > coronary artery > popliteal artery > carotid artery A .
A “After I workout my abs, I grab a Corona and pop my collar up to my carotid.”
ICA
ECA
CCA
RISK FACTORS Modifiable: smoking, hypertension, dyslipidemia ( LDL, HDL), diabetes. Non-modifiable: age,
sex ( in men and postmenopausal women), family history.
SYMPTOMS Angina, claudication, but can be asymptomatic.
PROGRESSION Inflammation important in pathogenesis: endothelial cell dysfunction macrophage and LDL
B accumulation foam cell formation fatty streaks smooth muscle cell migration (involves
PDGF and FGF), proliferation, and extracellular matrix deposition fibrous plaque complex
atheromas B .
Aortic aneurysm Localized pathologic dilatation of the aorta. May cause abdominal and/or back pain, which is a
sign of leaking, dissection, or imminent rupture.
Abdominal aortic Associated with atherosclerosis. Risk factors include history of tobacco use, age, male sex, family
aneurysm history. May present as palpable pulsatile abdominal mass (arrows in A point to outer dilated
A calcified aortic wall, with partial crescent-shaped non-opacification of aorta due to flap/clot). Most
often infrarenal (distal to origin of renal arteries).
Liver
Sp
Thoracic aortic Associated with cystic medial degeneration. Risk factors include hypertension, bicuspid aortic
aneurysm valve, connective tissue disease (eg, Marfan syndrome). Also associated with 3° syphilis
(obliterative endarteritis of the vasa vasorum). Aortic root dilatation may lead to aortic valve
regurgitation.
Traumatic aortic Due to trauma and/or deceleration injury, most commonly at aortic isthmus (proximal descending
rupture aorta just distal to origin of left subclavian artery).
Aortic dissection Longitudinal intimal tear forming a false lumen. Associated with hypertension, bicuspid aortic
A
valve, inherited connective tissue disorders (eg, Marfan syndrome). Can present with tearing,
Ao
sudden-onset chest pain radiating to the back +/− markedly unequal BP in arms. CXR shows
mediastinal widening. Can result in organ ischemia, aortic rupture, death. Two types:
Stanford type A (proximal): involves Ascending aorta A . May extend to aortic arch or
descending aorta. May result in acute aortic regurgitation or cardiac tamponade. Treatment:
surgery.
Stanford type B (distal): involves only descending aorta (Below ligamentum arteriosum). Treat
medically with β-blockers, then vasodilators.
RV RV LV LV RV RV LV LV
V5 V5 V5 V5
ST ST
ST ST
Evolution of Commonly occluded coronary arteries: LAD > RCA > circumflex.
myocardial infarction Symptoms: diaphoresis, nausea, vomiting, severe retrosternal pain, pain in left arm and/or jaw,
shortness of breath, fatigue.
TIME GROSS LIGHT MICROSCOPE COMPLICATIONS
0–24 hr None Early coagulative necrosis, Ventricular arrhythmia, HF,
release of necrotic cell cardiogenic shock.
contents into blood; edema,
hemorrhage, wavy fibers.
Occluded Neutrophils appear.
artery
Reperfusion injury,
associated with generation
Infarct of free radicals, leads to
Dark mottling; hypercontraction of myofibrils
pale with through free calcium influx.
tetrazolium
stain
Hyperemia
Gray-white
RV LV
Pap
LV
Acute coronary Unstable angina/NSTEMI—Anticoagulation (eg, heparin), antiplatelet therapy (eg, aspirin)
syndrome treatments + ADP receptor inhibitors (eg, clopidogrel), β-blockers, ACE inhibitors, statins. Symptom control
with nitroglycerin and morphine.
STEMI—In addition to above, reperfusion therapy most important (percutaneous coronary
intervention preferred over fibrinolysis).
Cardiomyopathies
Dilated Most common cardiomyopathy (90% of cases). Leads to systolic dysfunction.
cardiomyopathy Often idiopathic or familial. Other etiologies Dilated cardiomyopathy displays eccentric
A
include chronic Alcohol abuse, wet Beriberi, hypertrophy A (sarcomeres added in series).
Coxsackie B viral myocarditis, chronic ABCCCD.
Cocaine use, Chagas disease, Doxorubicin Takotsubo cardiomyopathy: broken heart
RV toxicity, hemochromatosis, sarcoidosis, syndrome—ventricular apical ballooning likely
LV
thyrotoxicosis, peripartum cardiomyopathy. due to increased sympathetic stimulation (eg,
Findings: HF, S3, systolic regurgitant murmur, stressful situations).
dilated heart on echocardiogram, balloon
appearance of heart on CXR.
Treatment: Na+ restriction, ACE inhibitors,
β-blockers, diuretics, digoxin, ICD, heart
transplant.
Hypertrophic 60–70% of cases are familial, autosomal Diastolic dysfunction ensues.
obstructive dominant (most commonly due to mutations Marked ventricular concentric hypertrophy
cardiomyopathy in genes encoding sarcomeric proteins, such (sarcomeres added in parallel) B , often septal
B
as myosin binding protein C and β-myosin predominance. Myofibrillar disarray and
heavy chain). Causes syncope during exercise fibrosis.
and may lead to sudden death (eg, in young Physiology of HOCM—asymmetric septal
LV athletes) due to ventricular arrhythmia. hypertrophy and systolic anterior motion of
RV
Findings: S4, systolic murmur. May see mitral mitral valve outflow obstruction dyspnea,
regurgitation due to impaired mitral valve possible syncope.
closure. Other causes of concentric LV hypertrophy:
Treatment: cessation of high-intensity athletics, chronic HTN, Friedreich ataxia.
use of β-blocker or non-dihydropyridine Ca2+
channel blockers (eg, verapamil). ICD if
patient is high risk.
Restrictive/infiltrative Postradiation fibrosis, Löffler endocarditis, Diastolic dysfunction ensues. Can have low-
cardiomyopathy Endocardial fibroelastosis (thick fibroelastic voltage ECG despite thick myocardium
tissue in endocardium of young children), (especially in amyloidosis).
Amyloidosis, Sarcoidosis, Hemochromatosis Löffler endocarditis—associated with
(although dilated cardiomyopathy is more hypereosinophilic syndrome; histology shows
common) (Puppy LEASH). eosinophilic infiltrates in myocardium.
Heart failure Clinical syndrome of cardiac pump dysfunction congestion and low perfusion. Symptoms
A
include dyspnea, orthopnea, fatigue; signs include S3 heart sound, rales, jugular venous distention
(JVD), pitting edema A .
Systolic dysfunction—reduced EF, EDV; contractility often 2° to ischemia/MI or dilated
cardiomyopathy.
Diastolic dysfunction—preserved EF, normal EDV; compliance ( EDP) often 2° to myocardial
hypertrophy.
Right HF most often results from left HF. Cor pulmonale refers to isolated right HF due to
pulmonary cause.
ACE inhibitors or angiotensin II receptor blockers, β-blockers (except in acute decompensated HF),
and spironolactone mortality. Thiazide or loop diuretics are used mainly for symptomatic relief.
Hydralazine with nitrate therapy improves both symptoms and mortality in select patients.
Paroxysmal Breathless awakening from sleep: venous return from redistribution of blood, reabsorption of
nocturnal dyspnea peripheral edema, etc.
Pulmonary edema pulmonary venous pressure pulmonary venous distention and transudation of fluid. Presence
of hemosiderin-laden macrophages (“HF” cells) in lungs.
Right heart failure
Hepatomegaly central venous pressure resistance to portal flow. Rarely, leads to “cardiac cirrhosis.”
(nutmeg liver)
Jugular venous venous pressure.
distention
Peripheral edema venous pressure fluid transudation.
↑
LV contractility
↑
Pulmonary venous cardiac
congestion output
↑ preload
↑ cardiac output
(compensation)
Shock Inadequate organ perfusion and delivery of nutrients necessary for normal tissue and cellular
function. Initially may be reversible but life threatening if not treated promptly.
PCWP SVR
CAUSED BY SKIN (PRELOAD) CO (AFTERLOAD) TREATMENT
Hypovolemic shock Hemorrhage, dehydration, Cold, IV fluids
burns clammy
Cardiogenic shock Acute MI, HF, valvular Inotropes, diuresis
dysfunction, arrhythmia
Cold, Relieve obstruction
or
Obstructive shock Cardiac tamponade, clammy
pulmonary embolism,
tension pneumothorax
Distributive shock Sepsis, anaphylaxis Warm IV fluids, pressors,
CNS injury Dry epinephrine
(anaphylaxis)
Acute pericarditis Inflammation of the pericardium [ A , red arrows]. Commonly presents with sharp pain, aggravated
A
by inspiration, and relieved by sitting up and leaning forward. Often complicated by pericardial
effusion [between yellow arrows in A ]. Presents with friction rub. ECG changes include
widespread ST-segment elevation and/or PR depression.
Causes include idiopathic (most common; presumed viral), confirmed infection (eg,
coxsackievirus B), neoplasia, autoimmune (eg, SLE, rheumatoid arthritis), uremia, cardiovascular
(acute STEMI or Dressler syndrome), radiation therapy.
Myocarditis Inflammation of myocardium global enlargement of heart and dilation of all chambers. Major
cause of SCD in adults < 40 years old.
Presentation highly variable, can include dyspnea, chest pain, fever, arrhythmias (persistent
tachycardia out of proportion to fever is characteristic).
Multiple causes:
Viral (eg, adenovirus, coxsackie B, parvovirus B19, HIV, HHV-6); lymphocytic infiltrate with
focal necrosis highly indicative of viral myocarditis.
Parasitic (eg, Trypanosoma cruzi, Toxoplasma gondii)
Bacterial (eg, Borrelia burgdorferi, Mycoplasma pneumoniae)
Toxins (eg, carbon monoxide, black widow venom)
Rheumatic fever
Drugs (eg, doxorubicin, cocaine)
Autoimmune (eg, Kawasaki disease, sarcoidosis, SLE, polymyositis/dermatomyositis)
Complications include sudden death, arrhythmias, heart block, dilated cardiomyopathy, HF, mural
thrombus with systemic emboli.
Cardiac tamponade Compression of the heart by fluid (eg, blood, effusions [arrows in A ] in pericardial space) CO.
A Equilibration of diastolic pressures in all 4 chambers.
Findings: Beck triad (hypotension, distended neck veins, distant heart sounds), HR, pulsus
paradoxus. ECG shows low-voltage QRS and electrical alternans (due to “swinging” movement of
RV heart in large effusion).
LV
Pulsus paradoxus— in amplitude of systolic BP by > 10 mm Hg during inspiration. Seen in
cardiac tamponade, asthma, obstructive sleep apnea, pericarditis, croup.
Syphilitic heart 3° syphilis disrupts the vasa vasorum of the Can result in aneurysm of ascending aorta or
disease aorta with consequent atrophy of vessel wall aortic arch, aortic insufficiency.
and dilatation of aorta and valve ring.
May see calcification of aortic root, ascending
aortic arch, and thoracic aorta. Leads to “tree
bark” appearance of aorta.
Vasculitides
EPIDEMIOLOGY/PRESENTATION PATHOLOGY/LABS
Large-vessel vasculitis
Giant cell (temporal) Usually elderly females. Most commonly affects branches of carotid
arteritis Unilateral headache (temporal artery), jaw artery.
claudication. Focal granulomatous inflammation A .
May lead to irreversible blindness due to ESR.
ophthalmic artery occlusion. Treat with high-dose corticosteroids prior to
Associated with polymyalgia rheumatica. temporal artery biopsy to prevent blindness.
Takayasu arteritis Usually Asian females < 40 years old. Granulomatous thickening and narrowing of
“Pulseless disease” (weak upper extremity aortic arch and proximal great vessels B .
pulses), fever, night sweats, arthritis, myalgias, ESR.
skin nodules, ocular disturbances. Treat with corticosteroids.
Medium-vessel vasculitis
Polyarteritis nodosa Usually middle-aged men. Typically involves renal and visceral vessels, not
Hepatitis B seropositivity in 30% of patients. pulmonary arteries.
Fever, weight loss, malaise, headache. Transmural inflammation of the arterial wall
GI: abdominal pain, melena. with fibrinoid necrosis.
Hypertension, neurologic dysfunction, Different stages of inflammation may coexist in
cutaneous eruptions, renal damage. different vessels.
Innumerable renal microaneurysms C and spasms
on arteriogram.
Treat with corticosteroids, cyclophosphamide.
Kawasaki disease Asian children < 4 years old. CRASH and burn.
(mucocutaneous Conjunctival injection, Rash (polymorphous May develop coronary artery aneurysms E ;
lymph node desquamating), Adenopathy (cervical), thrombosis or rupture can cause death.
syndrome) Strawberry tongue (oral mucositis) D , Hand- Treat with IV immunoglobulin and aspirin.
foot changes (edema, erythema), fever.
Buerger disease Heavy smokers, males < 40 years old. Segmental thrombosing vasculitis with vein and
(thromboangiitis Intermittent claudication may lead to nerve involvement.
obliterans) gangrene F , autoamputation of digits, Treat with smoking cessation.
superficial nodular phlebitis.
Raynaud phenomenon is often present.
Small-vessel vasculitis
Granulomatosis Upper respiratory tract: perforation of nasal Triad:
with polyangiitis septum, chronic sinusitis, otitis media, Focal necrotizing vasculitis
(Wegener) mastoiditis. Necrotizing granulomas in the lung and
Lower respiratory tract: hemoptysis, cough, upper airway
dyspnea. Necrotizing glomerulonephritis
Renal: hematuria, red cell casts. PR3-ANCA/c-ANCA G (anti-proteinase 3).
CXR: large nodular densities.
Treat with cyclophosphamide, corticosteroids.
Microscopic Necrotizing vasculitis commonly involving No granulomas.
polyangiitis lung, kidneys, and skin with pauci-immune MPO-ANCA/p-ANCA H (anti-
glomerulonephritis and palpable purpura. myeloperoxidase).
Presentation similar to granulomatosis with Treat with cyclophosphamide, corticosteroids.
polyangiitis but without nasopharyngeal
involvement.
Vasculitides (continued)
EPIDEMIOLOGY/PRESENTATION PATHOLOGY/LABS
LAD
AAo
F G H I J
Ao
Rhabdomyomas Most frequent 1° cardiac tumor in children (associated with tuberous sclerosis). Histology:
hamartomatous growths.
Hereditary Also known as Osler-Weber-Rendu syndrome. Inherited disorder of blood vessels. Findings:
hemorrhagic blanching lesions (telangiectasias) on skin and mucous membranes, recurrent epistaxis, skin
telangiectasia discolorations, arteriovenous malformations (AVMs), GI bleeding, hematuria.
CARDIOVASCULAR—PHARMACOLOGY
``
Hypertension treatment
Primary (essential) Thiazide diuretics, ACE inhibitors, angiotensin
hypertension II receptor blockers (ARBs), dihydropyridine
Ca2+ channel blockers.
Hypertension with Diuretics, ACE inhibitors/ARBs, β-blockers β-blockers must be used cautiously in
heart failure (compensated HF), aldosterone antagonists. decompensated HF and are contraindicated in
cardiogenic shock.
In HF, ARBs may be combined with the
neprilysin inhibitor sacubitril.
Hypertension with ACE inhibitors/ARBs, Ca2+ channel blockers, ACE inhibitors/ARBs are protective against
diabetes mellitus thiazide diuretics, β-blockers. diabetic nephropathy.
Hypertension in ARBs, Ca2+ channel blockers, thiazide diuretics, Avoid nonselective β-blockers to prevent
asthma selective β-blockers. β2‑receptor–induced bronchoconstriction.
Avoid ACE inhibitors to prevent confusion
between drug or asthma-related cough.
Hypertension in Hydralazine, labetalol, methyldopa, nifedipine. “He likes my neonate.”
pregnancy
Calcium channel Amlodipine, clevidipine, nicardipine, nifedipine, nimodipine (dihydropyridines, act on vascular
blockers smooth muscle); diltiazem, verapamil (non-dihydropyridines, act on heart).
MECHANISM Block voltage-dependent L-type calcium channels of cardiac and smooth muscle muscle
contractility.
Vascular smooth muscle—amlodipine = nifedipine > diltiazem > verapamil.
Heart—verapamil > diltiazem > amlodipine = nifedipine (verapamil = ventricle).
CLINICAL USE Dihydropyridines (except nimodipine): hypertension, angina (including Prinzmetal), Raynaud
phenomenon.
Nimodipine: subarachnoid hemorrhage (prevents cerebral vasospasm).
Nicardipine, clevidipine: hypertensive urgency or emergency.
Non-dihydropyridines: hypertension, angina, atrial fibrillation/flutter.
ADVERSE EFFECTS Non-dihydropyridine: cardiac depression, AV block, hyperprolactinemia, constipation, gingival
hyperplasia.
Dihydropyridine: peripheral edema, flushing, dizziness.
Hydralazine
MECHANISM cGMP smooth muscle relaxation. Vasodilates arterioles > veins; afterload reduction.
CLINICAL USE Severe hypertension (particularly acute), HF (with organic nitrate). Safe to use during pregnancy.
Frequently coadministered with a β-blocker to prevent reflex tachycardia.
ADVERSE EFFECTS Compensatory tachycardia (contraindicated in angina/CAD), fluid retention, headache, angina.
SLE-like syndrome.
Antianginal therapy Goal is reduction of myocardial O2 consumption (MVO2) by 1 or more of the determinants of
MVO2: end-diastolic volume, BP, HR, contractility.
COMPONENT NITRATES β-BLOCKERS NITRATES + β-BLOCKERS
End-diastolic volume No effect or No effect or
Blood pressure
Contractility No effect Little/no effect
Heart rate (reflex response) No effect or
Ejection time Little/no effect
MVO2
Verapamil is similar to β-blockers in effect.
Pindolol and acebutolol are partial β-agonists that should be used with caution in angina.
Ranolazine
MECHANISM Inhibits the late phase of sodium current thereby reducing diastolic wall tension and oxygen
consumption. Does not affect heart rate or contractility.
CLINICAL USE Angina refractory to other medical therapies.
ADVERSE EFFECTS Constipation, dizziness, headache, nausea, QT prolongation.
Milrinone
MECHANISM Selective PDE-3 inhibitor. In cardiomyocytes: cAMP accumulation Ca2+ influx inotropy
and chronotropy. In vascular smooth muscle: cAMP accumulation inhibition of MLCK
activity general vasodilation.
CLINICAL USE Short-term use in acute decompensated HF.
ADVERSE EFFECTS Arrhythmias, hypotension.
Lipid-lowering agents
DRUG LDL HDL TRIGLYCERIDES MECHANISMS OF ACTION ADVERSE EFFECTS/PROBLEMS
HMG-CoA reductase Inhibit conversion of HMG- Hepatotoxicity ( LFTs),
inhibitors CoA to mevalonate, a myopathy (esp. when used
(eg, lovastatin, cholesterol precursor; with fibrates or niacin)
pravastatin) mortality in CAD patients
Bile acid resins Slightly Slightly Prevent intestinal reabsorption GI upset, absorption of
Cholestyramine, of bile acids; liver must use other drugs and fat-soluble
colestipol, cholesterol to make more vitamins
colesevelam
Ezetimibe /— /— Prevent cholesterol absorption Rare LFTs, diarrhea
at small intestine brush
border
Fibrates Upregulate LPL TG Myopathy ( risk with
Gemfibrozil, clearance statins), cholesterol
bezafibrate, Activates PPAR-α to induce gallstones (via inhibition of
fenofibrate HDL synthesis cholesterol 7α-hydroxylase)
Niacin (vitamin B3) Inhibits lipolysis (hormone- Red, flushed face, which is
sensitive lipase) in adipose by NSAIDs or long-term
tissue; reduces hepatic VLDL use
synthesis Hyperglycemia
Hyperuricemia
PCSK9 inhibitors Inactivation of LDL-receptor Myalgias, delirium,
Alirocumab, degradation, increasing dementia, other
evolocumab amount of LDL removed neurocognitive effects
from bloodstream
LDL-RECEPTOR
DEGRADATION Niacin
PCSK9 inhibitors
Alirocumab
Evolocumab
↑TnC Ca 2+ ↑ cardiac
SR ↑↑Ca2+ binding contraction
CLINICAL USE HF ( contractility); atrial fibrillation ( conduction at AV node and depression of SA node).
ADVERSE EFFECTS Cholinergic—nausea, vomiting, diarrhea, blurry yellow vision (think van Gogh), arrhythmias, AV
block.
Can lead to hyperkalemia, which indicates poor prognosis.
Factors predisposing to toxicity: renal failure ( excretion), hypokalemia (permissive for digoxin
binding at K+-binding site on Na+/K+ ATPase), drugs that displace digoxin from tissue-binding
sites, and clearance (eg, verapamil, amiodarone, quinidine).
ANTIDOTE Slowly normalize K+, cardiac pacer, anti-digoxin Fab fragments, Mg2+.
Antiarrhythmics— Slow or block () conduction (especially in depolarized cells). slope of phase 0 depolarization. Are
sodium channel state dependent (selectively depress tissue that is frequently depolarized [eg, tachycardia]).
blockers (class I)
Class IA Quinidine, Procainamide, Disopyramide. Class IA
“The Queen Proclaims Diso’s pyramid.” 0 mV
Class IA
MECHANISM AP duration, effective refractory period
Slope of
(ERP) in ventricular action potential, QT 0 mV
phase 0
INa
interval, some potassium channel blocking Slope of
effects. phase 0
INa
CLINICAL USE Both atrial and ventricular arrhythmias,
especially re-entrant and ectopic SVT and VT.
ADVERSE EFFECTS Cinchonism (headache, tinnitus with
quinidine), reversible SLE-like syndrome
(procainamide), HF (disopyramide),
thrombocytopenia, torsades de pointes due to
Class IB
QT interval.
Class IB Lidocaine, MexileTine. 0 mV
Class IB
Slope of
“I’d Buy Liddy’s Mexican Tacos.” phase 0
0 mV INa
MECHANISM AP duration. Preferentially affect ischemic or Slope of
depolarized Purkinje and ventricular tissue. phase 0
INa
Phenytoin can also fall into the IB category.
CLINICAL USE Acute ventricular arrhythmias (especially post-
MI), digitalis-induced arrhythmias.
IB is Best post-MI.
ADVERSE EFFECTS CNS stimulation/depression, cardiovascular
depression.
Class IC Flecainide, Propafenone. Class IC
“Can I have Fries, Please.”
0 mV Class IC
MECHANISM Significantly prolongs ERP in AV node and
accessory bypass tracts. No effect on ERP in Slope of
0 mV
phase 0
Purkinje and ventricular tissue. INa
Minimal effect on AP duration. Slope of
phase 0
CLINICAL USE SVTs, including atrial fibrillation. Only as a last INa
resort in refractory VT.
ADVERSE EFFECTS Proarrhythmic, especially post-MI
(contraindicated). IC is Contraindicated in
structural and ischemic heart disease.
0
–30 Threshold
potential
–60
–90
0 100 200 300 400 500 600 700
Time (ms)
Pacemaker cell action potential
0 mV
Markedly prolonged
repolarization (IK)
−85 mV
Cell action potential
–30 Threshold
potential
–60
–90
0 100 200 300 400 500 600 700
Time (ms)
Other antiarrhythmics
Adenosine K+ out of cells hyperpolarizing the cell and ICa, decreasing AV node conduction. Drug of
choice in diagnosing/terminating certain forms of SVT. Very short acting (~ 15 sec). Effects
blunted by theophylline and caffeine (both are adenosine receptor antagonists). Adverse effects
include flushing, hypotension, chest pain, sense of impending doom, bronchospasm.
Mg2+ Effective in torsades de pointes and digoxin toxicity.
Ivabradine
MECHANISM Selective inhibition of funny sodium channels (If ), prolonging slow depolarization phase (phase 4).
SA node firing; negative chronotropic effect without inotropy. Reduces cardiac O2 requirement.
CLINICAL USE Chronic stable angina in patients who cannot take β-blockers. Chronic HF with reduced ejection
fraction.
ADVERSE EFFECTS Luminous phenomena/visual brightness, hypertension, bradycardia.
NOTES
``